Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells 215 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 215 shares of the stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $552.07, for a total value of $118,695.05. Following the completion of the transaction, the senior vice president now directly owns 1,338 shares in the company, valued at approximately $738,669.66. This represents a 13.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Monday, June 2nd, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $549.06, for a total transaction of $118,047.90.
• On Friday, May 16th, Mark Brosius sold 20 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.81, for a total transaction of $11,276.20.
• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.00, for a total transaction of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The shares were sold at an average price of $551.97, for a total transaction of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $6.10 during midday trading on Wednesday, hitting $557.95. 1,146,710 shares of the company's stock were exchanged, compared to its average volume of 1,648,262. Intuitive Surgical, Inc. has a 12 month low of $405.08 and a 12 month high of $616.00. The company has a market cap of $199.98 billion, a PE ratio of 87.04, a P/E/G ratio of 5.85 and a beta of 1.67. The firm has a 50-day moving average of $518.20 and a two-hundred day moving average of $538.82.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period last year, the business posted $1.50 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Sycomore Asset Management grew its position in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Castleark Management LLC raised its stake in Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after acquiring an additional 2,990 shares during the last quarter. Truist Financial Corp lifted its position in Intuitive Surgical by 3.0% during the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock worth $129,494,000 after acquiring an additional 7,298 shares during the period. Global X Japan Co. Ltd. grew its stake in Intuitive Surgical by 9.8% during the 4th quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider's stock valued at $24,161,000 after purchasing an additional 4,140 shares during the last quarter. Finally, Northeast Investment Management increased its holdings in shares of Intuitive Surgical by 3.1% in the fourth quarter. Northeast Investment Management now owns 89,170 shares of the medical equipment provider's stock valued at $46,543,000 after purchasing an additional 2,685 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Citigroup reissued a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Evercore ISI reduced their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Piper Sandler cut their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Five investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.